Denosumab Counteracts Metabolic Bone Disease in Chronic Intestinal Failure Patients: A Randomized, Controlled Clinical Trial
Latest Information Update: 05 Aug 2016
At a glance
- Drugs Denosumab (Primary)
- Indications Metabolic bone diseases
- Focus Therapeutic Use
- Acronyms Denoz
- 05 Aug 2016 New trial record